CN Stock MarketDetailed Quotes
002793 Luoxin Pharmaceuticals Group Stock
- 4.54
- -0.08-1.73%
Market Closed Dec 13 15:00 CST
4.94BMarket Cap-7.08P/E (TTM)
4.72High4.54Low266.54KlotVolume4.61Open4.62Pre Close123.18MTurnover2.45%Turnover RatioLossP/E (Static)1.09BShares5.8052wk High2.35P/B4.93BFloat Cap3.2252wk Low5.08Limit Up1.09BShs Float27.94Historical High4.16Limit Down3.90%Amplitude3.22Historical Low--Dividend TTM4.62Avg Price136.19KlotAsk--Div YieldTTM100Lot Size125.52KlotBid
Luoxin Pharmaceuticals Group Stock Key Stats
All
YOY
| (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Current assets | ||||||||||
| Money funds | -29.16%682.81M | -26.11%898.31M | -40.15%723.87M | -51.67%692.9M | -25.55%963.87M | -18.02%1.22B | -10.07%1.21B | -28.37%1.43B | -13.48%1.29B | 19.76%1.48B |
| Transactional financial assets | -70.42%2.1M | -74.07%2.1M | -76.92%2.1M | -87.72%2.1M | -53.46%7.1M | 53.47%8.1M | 700.82%9.1M | 35.95%17.1M | 90.69%15.26M | -72.22%5.28M |
| Notes receivable and accounts receivable | -29.92%464.95M | -34.34%445.94M | -34.38%491.85M | -41.92%504.54M | -81.80%663.47M | -83.62%679.15M | -83.04%749.58M | -72.40%868.64M | -0.13%3.65B | 23.63%4.15B |
| -Notes receivable | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -80.97%4.89M | -56.49%4.7M |
| -Accounts receivable | -29.92%464.95M | -34.34%445.94M | -34.38%491.85M | -41.92%504.54M | -81.78%663.47M | -83.60%679.15M | -83.03%749.58M | -72.28%868.64M | 0.44%3.64B | 23.89%4.14B |
| Other receivables (including interest and dividends) | -4.71%104.22M | -73.39%105.49M | -80.74%132.5M | -90.88%115.71M | -33.89%109.36M | 154.46%396.5M | 559.33%687.96M | 1,477.58%1.27B | 82.79%165.43M | 152.99%155.82M |
| -Dividend receivable | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --85M | ---- | ---- |
| -Other receivable | ---- | -73.39%105.49M | ---- | ---- | ---- | 154.46%396.5M | ---- | 1,371.95%1.18B | ---- | 152.99%155.82M |
| Advance payment | 99.33%106.55M | 303.01%166.96M | 121.66%127.49M | -28.50%36.42M | -61.37%53.46M | -62.83%41.43M | -62.54%57.52M | -45.27%50.94M | -2.47%138.39M | -31.21%111.45M |
| Inventories | -5.73%535.3M | -12.82%522.8M | -27.40%419.73M | -33.49%455.61M | -38.21%567.86M | -20.52%599.66M | -10.21%578.16M | -3.40%684.99M | 33.79%919M | -3.79%754.45M |
| Receivable financing | -77.42%10.96M | -59.21%34.64M | -71.08%50.63M | -26.10%94.35M | -20.40%48.52M | -7.81%84.93M | 46.17%175.06M | 17.83%127.66M | -17.33%60.95M | 146.08%92.12M |
| Assets held for sale | ---- | --21.13M | --19.29M | --25.01M | ---- | ---- | ---- | ---- | ---- | ---- |
| Non-current assets due within one year | --82.99M | --82.99M | --82.99M | --82.99M | ---- | ---- | ---- | ---- | ---- | ---- |
| Other current assets | -52.57%53.84M | -60.68%67.79M | -73.75%61.44M | -78.52%57.87M | -20.16%113.51M | 45.40%172.39M | 161.25%234.09M | 61.11%269.4M | 45.30%142.17M | 5.23%118.56M |
| Total current assets | -19.13%2.04B | -26.57%2.35B | -42.94%2.11B | -56.21%2.07B | -60.40%2.53B | -53.78%3.2B | -46.57%3.7B | -25.85%4.72B | 2.18%6.38B | 19.93%6.92B |
| Non Current assets | ||||||||||
| Other equity investment | -2.40%60.84M | -2.90%61.88M | 1.64%61.6M | -1.58%60.43M | -0.45%62.34M | 7.62%63.73M | 1.87%60.6M | -5.89%61.4M | 1.00%62.62M | -10.87%59.22M |
| Other non-current financial assets | --1.25M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Investment real estate | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -2.15%30.05M | -2.14%30.54M |
| Long-term equity investment | 1.14%172.19M | 4.02%177.86M | 4.91%181.58M | 8.25%184.63M | --170.24M | --170.98M | --173.07M | --170.56M | ---- | ---- |
| Long term receivable account | -80.81%45.01M | -81.18%45.01M | -47.96%124.49M | -47.96%124.49M | --234.61M | --239.21M | --239.21M | --239.21M | ---- | ---- |
| Fixed assets | ---- | -13.22%1.17B | ---- | ---- | ---- | -19.92%1.35B | ---- | -14.06%1.41B | ---- | 2.00%1.68B |
| Constru in process | ---- | 16.96%363.21M | ---- | ---- | ---- | 3.43%310.55M | ---- | -18.81%294.22M | ---- | -5.28%300.26M |
| Intangible assets | 18.82%470.51M | 17.83%457.03M | 19.12%466.52M | 21.24%476.24M | -24.73%395.99M | -27.23%387.89M | 16.66%391.64M | 16.18%392.81M | 54.43%526.08M | 55.80%533.06M |
| Development expenditure | -10.10%256.74M | -10.75%250.34M | -7.88%232.67M | -11.33%224.91M | 40.80%285.58M | 55.03%280.49M | -23.58%252.57M | -18.75%253.66M | -31.71%202.83M | -32.09%180.93M |
| Goodwill | -55.39%1.95M | -55.39%1.95M | -55.39%1.95M | -55.39%1.95M | -59.31%4.38M | -59.31%4.38M | -59.31%4.38M | -55.13%4.38M | 22.12%10.76M | 22.12%10.76M |
| Long deferred expense | -35.61%16.88M | -34.98%18.42M | -22.68%19.71M | -30.51%19.26M | -57.02%26.22M | -50.50%28.33M | -55.14%25.49M | -53.24%27.71M | -5.35%60.99M | -14.27%57.23M |
| Deferred tax assets | -32.63%261.47M | -32.56%279.26M | -33.39%284.1M | -33.24%286.15M | 36.59%388.09M | 90.56%414.11M | 120.27%426.51M | 133.36%428.61M | 69.91%284.12M | 87.77%217.31M |
| Usufruct assets | -44.06%37.71M | -42.65%39.32M | -39.39%42.26M | -38.07%45.66M | -32.05%67.42M | -34.41%68.55M | 7.41%69.73M | 7.15%73.72M | 80.40%99.22M | 81.78%104.52M |
| Other non current assets | -25.91%40.04M | -25.44%42.29M | -17.49%42.29M | 2.18%42.29M | -6.70%54.04M | -5.31%56.71M | -14.10%51.25M | -28.72%41.38M | 20.71%57.92M | 244.03%59.9M |
| Total non current assets | -14.60%2.85B | -13.83%2.91B | -10.40%3.01B | -10.22%3.05B | 1.23%3.33B | 4.21%3.37B | 7.16%3.35B | 8.58%3.4B | 7.60%3.29B | 10.12%3.24B |
| Total assets | -16.55%4.89B | -20.03%5.25B | -27.47%5.12B | -36.97%5.12B | -39.43%5.86B | -35.31%6.57B | -29.84%7.06B | -14.51%8.12B | 3.96%9.67B | 16.62%10.16B |
| Liabilities | ||||||||||
| Current liabilities | ||||||||||
| Short term loan | 6.77%946.49M | -14.85%1.07B | -48.25%803.15M | -76.64%555.6M | -67.91%886.44M | -43.33%1.26B | -24.34%1.55B | 22.96%2.38B | 142.17%2.76B | 252.88%2.22B |
| Transactional financial liabilities | --4.05M | --4.05M | --4.05M | --4.05M | ---- | ---- | ---- | ---- | ---- | ---- |
| Notes payable and accounts payable | 15.27%456.28M | 23.98%469.02M | 12.60%398.9M | -24.86%384.89M | -51.43%395.85M | -56.53%378.31M | -56.64%354.26M | -43.07%512.25M | -41.23%815.01M | -35.32%870.22M |
| -Notes payable | 227.57%7.3M | ---- | ---- | ---- | -98.15%2.23M | -91.87%7.58M | -92.80%8.39M | -43.17%79.97M | -84.53%120.73M | -87.04%93.15M |
| -Accounts payable | 14.06%448.98M | 26.51%469.02M | 15.33%398.9M | -10.96%384.89M | -43.31%393.62M | -52.29%370.73M | -50.62%345.86M | -43.05%432.28M | 14.50%694.28M | 24.02%777.07M |
| Contract liabilities | -23.13%86.06M | -18.86%107.96M | -18.40%131.28M | -20.68%134.28M | -34.42%111.95M | -1.97%133.05M | 23.67%160.88M | 13.76%169.28M | 78.81%170.71M | 25.24%135.72M |
| Advance receipts | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -27.88%3.42M | -7.53%3.68M |
| Salaries payable | -13.88%57.96M | -30.62%51.28M | -6.99%97.23M | -7.47%110.19M | -46.03%67.3M | -34.21%73.91M | -15.42%104.53M | -12.41%119.08M | 62.41%124.71M | 43.77%112.34M |
| Taxs payable | 39.62%13.32M | -47.69%13.25M | -2.34%19.32M | -31.78%15.41M | -71.46%9.54M | -58.06%25.33M | -79.32%19.78M | -90.11%22.59M | -85.30%33.43M | -72.48%60.39M |
| Other payable (including interest and dividends) | -49.98%98.85M | -44.35%107.5M | -53.78%123.82M | -16.54%223.48M | -53.75%197.62M | -69.05%193.17M | -65.94%267.89M | -23.75%267.75M | -11.55%427.28M | 8.98%624.13M |
| -Dividend payable | 0.00%1.27M | 0.00%1.27M | 0.00%1.27M | 0.00%1.27M | -0.32%1.27M | -6.63%1.27M | 103.63%1.27M | 103.63%1.27M | 45.55%1.27M | 118.08%1.36M |
| -Other payable | ---- | -44.64%106.23M | ---- | ---- | ---- | -69.19%191.9M | ---- | -23.97%266.48M | ---- | 8.86%622.77M |
| Hold and for sell liabilities | ---- | --6.66M | --8.39M | --11.29M | ---- | ---- | ---- | ---- | ---- | ---- |
| Non current liabilities due within one year | 103.15%734.27M | 23.12%726.58M | -9.89%648.52M | -47.06%469.38M | -40.40%361.44M | -6.24%590.12M | 72.68%719.72M | 207.49%886.6M | 219.17%606.41M | 270.25%629.42M |
| Other current liabilities | -34.30%9.56M | -31.09%11.92M | -39.34%12.87M | -52.71%8.99M | -34.18%14.55M | -2.03%17.3M | 25.46%21.22M | 9.80%19.01M | 77.91%22.11M | 20.89%17.66M |
| Total current liabilities | 17.71%2.41B | -3.75%2.57B | -29.77%2.25B | -56.17%1.92B | -58.82%2.04B | -42.89%2.67B | -27.94%3.2B | 9.17%4.37B | 37.21%4.97B | 48.82%4.68B |
| Current liabilities | ||||||||||
| Long term loan | -68.40%171.79M | -65.83%171.04M | -38.07%250.75M | 124.81%429.23M | 535.25%543.66M | 1.29%500.5M | -29.79%404.89M | -66.33%190.93M | -88.34%85.58M | -31.42%494.13M |
| Long term account payable | ---- | ---- | ---- | ---- | ---- | -44.95%52.88M | ---- | --79.14M | ---- | --96.06M |
| Estimate liabilities | --35.84M | --34.71M | --34.95M | --34.6M | ---- | ---- | ---- | ---- | --31.01M | --30.87M |
| Deferred tax liabilities | -15.52%6.21M | -17.91%6.8M | -23.08%7.21M | -26.29%7.58M | --7.35M | --8.28M | --9.38M | --10.29M | ---- | ---- |
| Long term deferred income | -5.29%81.79M | -4.64%84.56M | -3.99%87.18M | -3.90%89.93M | -25.13%86.36M | -24.41%88.67M | -20.95%90.8M | -8.46%93.58M | 0.76%115.34M | 13.64%117.3M |
| Lease liabilities | -48.32%32.77M | -43.67%33.13M | -35.87%37.95M | -37.86%39.07M | -26.96%63.41M | -37.64%58.82M | -12.52%59.18M | 10.06%62.88M | 53.21%86.81M | 60.85%94.32M |
| Total non current liabilities | -56.55%328.4M | -53.43%330.23M | -30.95%445.55M | 43.64%627.44M | 81.20%755.84M | -14.83%709.16M | -17.96%645.25M | -42.05%436.82M | -53.93%417.13M | -5.64%832.68M |
| Total liabilities | -2.33%2.74B | -14.17%2.9B | -29.97%2.69B | -47.11%2.54B | -47.97%2.8B | -38.65%3.38B | -26.44%3.85B | 1.06%4.81B | 18.97%5.38B | 36.88%5.51B |
| Shareholders equity | ||||||||||
| Paid-in capital | 0.00%1.09B | 0.00%1.09B | 0.00%1.09B | 0.00%1.09B | -25.45%1.09B | -25.45%1.09B | -25.70%1.09B | -25.70%1.09B | -0.34%1.46B | -0.57%1.46B |
| Capital reserve funds | -8.29%472.37M | -8.29%472.62M | -8.12%472.99M | -8.12%472.99M | 269.96%515.09M | 270.16%515.36M | 193.49%514.77M | 193.49%514.77M | -20.35%139.23M | -35.24%139.23M |
| Surplus reserve funds | 0.00%12.84M | 0.00%12.84M | 0.00%12.84M | 0.00%12.84M | --12.84M | --12.84M | --12.84M | --12.84M | ---- | ---- |
| Retained profit | -53.31%609.84M | -44.17%786.5M | -41.98%838.55M | -43.03%875.21M | -42.63%1.31B | -46.96%1.41B | -49.65%1.45B | -44.91%1.54B | -19.77%2.28B | -2.85%2.66B |
| Less:Treasury stock | --100M | --100M | --100M | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Other composite income | -26.45%21.49M | -35.45%23.46M | 13.09%22.59M | -8.82%21.27M | -5.60%29.21M | 208.01%36.34M | 309.16%19.97M | 950.45%23.33M | 527.21%30.94M | 407.39%11.8M |
| Shareholders equity without minority interests | -28.69%2.1B | -25.41%2.28B | -24.22%2.33B | -22.20%2.47B | -24.45%2.95B | -28.25%3.06B | -30.92%3.08B | -27.59%3.17B | -11.76%3.91B | -1.74%4.27B |
| Minority interests | -53.64%49.92M | -46.20%69.22M | -30.80%89.54M | -22.56%102.51M | -72.01%107.67M | -66.09%128.66M | -65.01%129.39M | -62.31%132.37M | 8.60%384.63M | 11.10%379.44M |
| Total shareholder equity | -29.57%2.15B | -26.25%2.35B | -24.48%2.42B | -22.22%2.57B | -28.71%3.06B | -31.34%3.19B | -33.53%3.21B | -30.16%3.31B | -10.25%4.29B | -0.80%4.65B |
| Total liabilityies and equity | -16.55%4.89B | -20.03%5.25B | -27.47%5.12B | -36.97%5.12B | -39.43%5.86B | -35.31%6.57B | -29.84%7.06B | -14.51%8.12B | 3.96%9.67B | 16.62%10.16B |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- |
| Auditor | -- | -- | -- | Tianjian Certified Public Accountants (Special General Partnership) | -- | -- | -- | Tianjian Certified Public Accountants (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Heat List
CN
Overall
Symbol
Price
% Chg
No Data
